FINWIRES · TerminalLIVE
FINWIRES
$UNH

$UNH

100 stories mentioning UNHUpdated 1h ago

Every FINWIRES story that references UNH, newest first.

What are analysts saying about UNH?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on UNH?

Wire

UnitedHealth Earnings Growth Outlook Unlikely to Change, UBS Says

UnitedHealth (UNH) has been facing investor questions surrounding the upcoming release of Medicare Advantage Stars data for payment year 2028, but the company's earnings growth guidance is unlikely to change, UBS Securities said in a note Monday.The company's shares have seen some weakness after a presentation at an investor event last week, UBS said, adding that investors "had a more nervous reaction to management's conference comments related to MA Stars than the company expected."Medicare Advantage Stars is a rating system that unlocks quality bonuses and increased rebate percentages for higher ratings, while low-rated plans can see financial penalties.The investment firm said that UnitedHealth's management indicated that it now has "considerable data" and is "comfortable with how the company is positioned."Given what UnitedHealth management currently understands about its Stars, UBS said, the company is comfortable that it can deliver mid-teens earnings growth annually from here, the note said.UBS has a buy rating on UnitedHealth and a $490 price target.Price: $383.96, Change: $+7.19, Percent Change: +1.91%

$UNH
Sectors

Sector Update: Healthcare Stocks Softer Late Afternoon

Healthcare stocks were lower late Wednesday afternoon with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each shedding 0.2%.The iShares Biotechnology ETF (IBB) declined 0.8%.In corporate news, UnitedHealth (UNH) sold an interest in some of its Optum Health operations in Florida to TPG (TPG), Bloomberg reported. UnitedHealth shares were down 2.2%.Agilent Technologies (A) shares fell 1.2% after UBS downgraded the stock to neutral from buy.Rezolute (RZLT) said Wednesday that the US Food and Drug Administration is still reviewing data from a phase 3 study of ersodetug for the potential treatment of hypoglycemia due to congenital hyperinsulinism. The company said it does not have a specific timeline on when it will receive feedback or guidance from the FDA on potential next steps. Rezolute shares were down past 7%.Opus Genetics (IRD) shares jumped 35% after it said that patients with Bestrophin-1-related retinal diseases showed clinically meaningful improvement in visual function in the low-dose cohort 1 of its BIRD-1 phase 1/2 trial evaluating OPGx-BEST1.

$A$IRD$RZLT$UNH
Sectors

Sector Update: Healthcare Stocks Decline in Afternoon Trading

Healthcare stocks were lower Wednesday afternoon, with the NYSE Healthcare Index down 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) easing 0.2%.The iShares Biotechnology ETF (IBB) decreased 0.6%.In corporate news, UnitedHealth (UNH) sold an interest in some of its Optum Health operations in Florida to TPG (TPG), Bloomberg reported. UnitedHealth shares were down 1.8%.Evommune's (EVMN) phase 2b trial of EVO756 to treat adults with moderate-to-severe atopic dermatitis didn't meet its primary and secondary endpoints in any of the doses studied, the company said. Its shares fell past 16%.Rezolute (RZLT) said Wednesday that the US Food and Drug Administration is still reviewing data from a phase 3 study of ersodetug for the potential treatment of hypoglycemia due to congenital hyperinsulinism. The company said it does not have a specific timeline on when it will receive feedback or guidance from the FDA on potential next steps. Rezolute shares were down past 7%.

$EVMN$RZLT$UNH
Sectors

Sector Update: Healthcare

Healthcare stocks declined Wednesday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each shedding 0.4%.The iShares Biotechnology ETF (IBB) decreased 0.7%.In corporate news, UnitedHealth (UNH) sold an interest in some of its Optum Health operations in Florida to TPG (TPG), Bloomberg reported. UnitedHealth shares were down 1.8%.

$UNH
Wire

Top Midday Stories: Meta Launches Muse Personal AI Agent; Dow Said to Consider Exiting $20 Billion Chemicals JV With Saudi Aramco

All three major US stock indexes were down in late-morning trading Wednesday, as oil prices climbed, stoking investor fears of rising inflation and a potential corresponding rise in interest rates.The US Treasury Department said Wednesday it will buy back up to $6 billion of longer-dated government debt, triple the amount initially communicated to market participants, according to media reports.In company news, Meta Platforms (META) has launched a new personal artificial intelligence agent called Muse AI, which can send emails, book travel plans, take on goals and continue working after users close the app. Meta shares were up 6.3% around midday.Dow (DOW) is considering plans to exit its $20 billion chemicals joint venture with Saudi Aramco, Bloomberg reported Wednesday, citing people familiar with the matter. Dow held a 35% stake in the venture, known as Sadara Chemical, as of last year, with Aramco holding the remainder, the report said. Saudi Aramco could acquire Dow's stake, or other strategic or financial investors could place bids for it, the report said, citing the people. Dow shares were down 1.2%.Chewy (CHWY) reported fiscal Q2 adjusted earnings Wednesday of $0.36 per diluted share, up from $0.33 a year earlier and matching the FactSet consensus analyst estimate. Fiscal Q2 net sales were $3.33 billion, up from $310 billion a year ago and above the FactSet consensus of $3.32 billion. An unidentified Chewy executive said on an earnings call with analysts that the company reset its expectations to reflect more cautious consumers earlier this year, and it is "not assuming a meaningful consumer recovery for the balance of this fiscal year," according to a FactSet transcript of the call. Chewy shares were down 9%.Apple (AAPL) is expected to unveil its first foldable phone, potentially called the iPhone Ultra, as well as the iPhone 18 Pro and Pro Max at 1 pm on Wednesday at an event, multiple media outlets reported. Separately, Apple, Alphabet (GOOG, GOOGL) and other major technology platforms will be required to stop children from taking, sharing or viewing nude images on their phones and tablets under proposed UK legislation, said Lisa Nandy, UK secretary of state for digital, culture, media and sport, Tuesday in a speech to Parliament. Apple shares were down 1.3%, while Alphabet's Class C and Class A shares were down 2.6% and 2.7%, respectively.UnitedHealth Group (UNH) sold an interest in some of its Optum Health operations in Florida to TPG (TPG), Bloomberg reported Wednesday. UnitedHealth shares were down 2.5%, while TPG shares were down 3.4%.Price: $652.46, Change: $+38.98, Percent Change: +6.35%

$AAPL$CHWY$DOW$GOOG$GOOGL$META$UNH
Wire

Market Chatter: HHS Plans 2 New FDA Deputy Commissioner Roles Covering Drugs, Technology

The US Department of Health and Human Services is planning to create two deputy commissioner roles at the Food and Drug Administration to focus on technology and drugs, respectively, CNBC reported Tuesday, citing sources.Specifically, the technology deputy commissioner role would focus on the intersection of health and artificial intelligence, the report said, citing the sources.HHS officials would appoint the new deputies in what some within the Trump administration view as an attempt to wield greater influence over the agency, the sources reportedly told CNBC.HHS didn't immediately reply to a request for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $398.06, Change: $-0.70, Percent Change: -0.18%

$CNC$CVS$ELV$HUM$UNH
Wire

HHS Plans 2 New FDA Deputy Commissioner Roles Covering Drugs, Technology, CNBC Reports

HHS Plans 2 New FDA Deputy Commissioner Roles Covering Drugs, Technology, CNBC Reports

$CNC$CVS$ELV$HUM$UNH
Wire

Update: Luigi Mangione Reportedly to Plead Guilty Over Former UnitedHealth Executive Killing, Lawyer Says

(Updates with the company's response in the fifth paragraph.)Luigi Mangione is expected to plead guilty to federal charges related to the killing of former UnitedHealth (UNH) executive Brian Thompson, according to his lawyer, multiple media outlets reported Friday.Mangione faces two counts of stalking in connection with Thompson's death in December 2024, Bloomberg said.Brian Thompson was the chief executive officer of UnitedHealthcare, the health insurance segment of UnitedHealth.In an email to, a UnitedHealth spokesman said, "Brian Thompson's life was cut short by an act of violence that devastated everyone who knew and loved him. We are grateful to law enforcement for bringing Brian's murderer to justice, and our thoughts remain with Brian's family and loved ones during this difficult time."The spokesman added that Mangione was never a member of UnitedHealthcare.Price: $396.64, Change: $-5.10, Percent Change: -1.27%

$UNH
Sectors

Sector Update: Healthcare Stocks Decline Late Afternoon

Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index decreasing 0.4% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.5%.The iShares Biotechnology ETF (IBB) lost 0.5%.In corporate news, Luigi Mangione is expected to plead guilty to federal charges related to the killing of former UnitedHealth (UNH) executive Brian Thompson, according to his lawyer, multiple media outlets reported Friday. UnitedHealth shares were up 0.8%.Valneva (VALN) shares jumped 25% after the company and Pfizer (PFE) said the European Medicines Agency validated their marketing authorization application for their Lyme disease vaccine candidate, starting the regulatory review process. Pfizer shares were fractionally lower.Eton Pharmaceuticals (ETON) shares surged 41%. The company late Thursday reported Q2 adjusted earnings and revenue above market expectations and raised full-year 2026 sales guidance.Zentalis Pharmaceuticals (ZNTL) shares fell past 12% in Friday trading, a day after the company priced an offering of 23 million shares at $3.50 each, targeting about $80.5 million in gross proceeds.

$ETON$PFE$UNH$VALN$ZNTL
Wire

Sector Update: Healthcare Stocks Decline Friday Afternoon

Healthcare stocks were lower Friday afternoon, with the NYSE Healthcare Index decreasing 0.5% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.6%.The iShares Biotechnology ETF (IBB) lost 0.6%.In corporate news, Luigi Mangione is expected to plead guilty to federal charges related to the killing of former UnitedHealth (UNH) executive Brian Thompson, according to his lawyer, multiple media outlets reported Friday. UnitedHealth shares were up 0.5%.Valneva (VALN) shares jumped 27% after the company and Pfizer (PFE) said the European Medicines Agency validated their marketing authorization application for their Lyme disease vaccine candidate, starting the regulatory review process. Pfizer shares were fractionally lower.Heartflow (HTFL) shares surged 33% after it posted a narrower Q2 non-GAAP loss, as revenue increased during the period, and raised its 2026 revenue outlook.

$HTFL$PFE$UNH$VALN
Sectors

Sector Update: Healthcare

Healthcare stocks were lower Friday afternoon, with the NYSE Healthcare Index decreasing 0.5% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.6%.The iShares Biotechnology ETF (IBB) declined 0.8%.In corporate news, Luigi Mangione is expected to plead guilty to federal charges related to the killing of former UnitedHealth (UNH) executive Brian Thompson, according to his lawyer, multiple media outlets reported Friday. Mangione faces two counts of stalking in connection with Thompson's death in December 2024, Bloomberg reported. UnitedHealth shares were up 0.5%.

$UNH
Wire

Luigi Mangione Reportedly to Plead Guilty Over Former UnitedHealth Executive Killing, Lawyer Says

Luigi Mangione is expected to plead guilty to federal charges related to the killing of former UnitedHealth (UNH) executive Brian Thompson, according to his lawyer, multiple media outlets reported Friday.Mangione faces two counts of stalking in connection with Thompson's death in December 2024, Bloomberg said.Brian Thompson was the chief executive officer of UnitedHealthcare, the health insurance segment of UnitedHealth.In an email to, a UnitedHealth spokesman said "Brian Thompson's life was cut short by an act of violence that devastated everyone who knew and loved him. We are grateful to law enforcement for bringing Brian's murderer to justice, and our thoughts remain with Brian's family and loved ones during this difficult time."Price: $401.84, Change: $+2.77, Percent Change: +0.70%

$UNH
Wire

Lawyer Says Luigi Mangione to Plead Guilty Over Former UNH Executive Killing, Bloomberg Reports

Lawyer Says Luigi Mangione to Plead Guilty Over Former UNH Executive Killing, Bloomberg Reports

$UNH
Wire

Lawyer Says Luigi Mangione to Plead Guilty Over former UNH Executive Killing, Bloomberg Reports

Lawyer Says Luigi Mangione to Plead Guilty Over former UNH Executive Killing, Bloomberg Reports

$UNH
Wire

Sector Update: Healthcare Stocks Softer Late Afternoon

Healthcare stocks were lower late Wednesday afternoon, with the NYSE Healthcare Index down 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) decreasing 0.8%.The iShares Biotechnology ETF (IBB) shed 0.9%.In corporate news, Hims & Hers Health (HIMS) is being sued by the US Federal Trade Commission, the State of California, and the Utah Division of Consumer Protection, for allegedly sharing users' data with Meta (META), Snap (SNAP) and other online advertising companies, court documents show. Hims & Hers Health shares fell past 14%.UnitedHealth (UNH) may lose significant funding as the Trump administration plans to terminate a Medicare prescription drug subsidy program, The Wall Street Journal reported. The government will end the $3.6 billion subsidy after 2026, which would have directed more than half of its funds to UnitedHealth next year, the report quoted the administration officials as saying. UnitedHealth shares were down 1.8%.Boston Scientific (BSX) lowered its full-year guidance below Wall Street's estimates on Wednesday, citing factors including weak demand for its Watchman heart implant. Its shares were down 1.5%.NeoGenomics (NEO) shares jumped past 15% after it reported better-than-expected Q2 results.

$BSX$HIMS$NEO$UNH
Sectors

Sector Update: Healthcare Stocks Edge Lower in Afternoon Trading

Healthcare stocks were slightly lower Wednesday afternoon, with the NYSE Healthcare Index down 0.1% and the State Street Health Care Select Sector SPDR ETF (XLV) fractionally lower.The iShares Biotechnology ETF (IBB) fell 0.7%.In corporate news, Hims & Hers Health (HIMS) is being sued by the US Federal Trade Commission for allegedly sharing users' data with Meta (META), Snap (SNAP) and other companies, Reuters reported. Hims & Hers Health shares dropped 11%.UnitedHealth (UNH) may lose significant funding as the Trump administration plans to terminate a Medicare prescription drug subsidy program, The Wall Street Journal reported. The government will end the $3.6 billion subsidy after 2026, which would have directed more than half of its funds to UnitedHealth next year, the report quoted the administration officials as saying. UnitedHealth shares were down 1.4%.Boston Scientific (BSX) lowered its full-year guidance below Wall Street's estimates on Wednesday, citing factors including weak demand for its Watchman heart implant. Its shares were up 0.8%.

$BSX$HIMS$UNH
Wire

Leerink Partners Adjusts UnitedHealth Group Price Target to $472 From $462

UnitedHealth Group (UNH) has an average rating of overweight and mean price target of $475.16, according to analysts polled by FactSet.Price: $428.70, Change: $+5.32, Percent Change: +1.26%

$UNH
Wire

UnitedHealth Poised for Further Growth Despite Employer Commercial Pressure, RBC Says

UnitedHealth Group's (UNH) Medicare Advantage business should continue to drive positive growth despite employer commercial pressure, RBC Capital Markets said in a Thursday note.Performance in Medicare Advantage significantly impacted the company's Q2 earnings beat, with a medical cost ratio of 86.7% that included $860 million of net favorable prior period development, according to the note.UnitedHealth priced its 2027 Medicare Advantage plan bids aiming for margin expansion, but stated that it may exit some geographies because the final MA payment rate increases are still lower than its cost levels, although it added that it expects to leave fewer markets in 2027 compared to this year, the note said.Employer commercial trends were worse than company expectations of around 11%. With the trends expected at the current elevated levels for the remainder of the year, UnitedHealth moved back its recovery timeline to achieve a target margin of 7% to beyond 2027, RBC said.Based on confidence in Medicare Advantage and Optum Health margin recovery, RBC raised its full-year adjusted EPS estimate to $19.76 from $18.28 and boosted its 2027 EPS estimate to $22.51 from $20.51.RBC reiterated the company's stock rating at outperform and increased the price target to $478 from $463.Price: $425.48, Change: $+2.10, Percent Change: +0.50%

$UNH
Wire

UBS Adjusts Price Target on UnitedHealth to $490 From $460, Maintains Buy Rating

UnitedHealth (UNH) has an average rating of overweight and mean price target of $474.28, according to analysts polled by FactSet.Price: $428.00, Change: $+4.62, Percent Change: +1.09%

$UNH
Update: Wall Street Snaps Two-Day Advance as Chip-Related Stocks Slump
US Markets

Update: Wall Street Snaps Two-Day Advance as Chip-Related Stocks Slump

(Updates with closing levels throughout the story.)Wall Street's stock indexes fell Thursday after a two-day advance, dragged down by a sell-off in chip-related stocks and certain mega-cap technology stocks.The tech-heavy Nasdaq Composite shed 1.5% to close at 25,881.95, while the S&P 500 dropped 0.5% to 7,533.77. The Dow Jones Industrial Average lost 0.2% to settle at 52,552.97.Most sectors were in the green, led by consumer staples, while communication services saw the biggest drop, followed by technology.Semiconductor company Sandisk (SNDK) was the worst performer on the S&P 500, down nearly 12%. Nvidia (NVDA) fell 2.4%, among the notable laggards on the Dow.Taiwan Semiconductor Manufacturing's (TSM) US-listed shares fell 2.3% after the semiconductor manufacturer reported its second-quarter results. The company earmarked an additional $100 billion to increase its chipmaking capacity in the US, Bloomberg News reported, citing a US official.Alphabet's (GOOGL) Class A shares slumped 4.4%, the second-worst performer on the Dow. Amazon.com (AMZN) also fell.In other corporate news, Abbott Laboratories (ABT) shares jumped nearly 11%, the biggest gainer on the S&P 500. The healthcare company lifted its full-year earnings outlook after reporting second-quarter results above market estimates.UnitedHealth (UNH) raised its full-year earnings guidance, as the health insurance giant recorded an unexpected year-over-year increase in its second-quarter revenue. The company's shares rose 1.2%.West Texas Intermediate crude oil was down 0.7% at $79.05 a barrel in Thursday late-afternoon trade, while Brent dropped 0.6% to $84.31."Oil prices slipped as traders assessed tensions between the (US) and Iran and the risks to oil supplies moving through the Strait of Hormuz," D.A. Davidson said in a note.Iran vowed to destroy key Middle East infrastructure if US President Donald Trump carries out his threat to hit Iranian infrastructure in the absence of a deal between the two countries, an Iranian military spokesperson reportedly said. Trump issued his warning in a recent interview with Fox News, CNBC reported.US Treasury yields were higher intraday, with the two-year rate up 2.3 basis points at 4.15% and the 10-year rate rising 1.4 basis points to 4.56%.Dallas Fed President Lorie Logan on Thursday pushed for "modestly higher" interest rates as she, along with her Kansas City counterpart Jeffrey Schmid, downplayed soft inflation data this week and flagged persistent price pressures.In economic news, US retail sales edged higher in June despite lower gasoline prices that drove a sharp decline in gas station receipts, official data showed.Pending home sales decreased more than projected in June amid high mortgage rates and prices, data from the National Association of Realtors showed.Homebuilder confidence deteriorated in July amid growing material prices, high land costs and elevated mortgage rates, the National Association of Home Builders and Wells Fargo said.Gold was down 1.7% at $3,983.20 per troy ounce, while silver lost 2.8% to $55.83 per ounce.

Dow JonesNasdaq CompositeS&P 500$ABT$AMZN$GOOGL$NVDA$SNDK$TSM$UNH

Showing 1-20 of 100

Track with the FINWIRES app suite